Perry Shen

Papers

Total Citations

H-Index

About

Perry Shen is a leading figure in surgical oncology, with a primary focus on minimally invasive and endoscopic approaches to complex gastrointestinal malignancies. His research centers on advancing treatment for unresectable malignant gastric outlet obstruction (GOO), a debilitating condition traditionally managed with enteral stenting or open surgery. Shen’s major contribution lies in pioneering comparative outcomes between novel techniques. His most cited work, a 2023 study comparing endoscopic ultrasound-guided gastrojejunostomy (EUS-GJ) using a lumen-apposing metal stent against robotic gastrojejunostomy, has garnered 19 citations, highlighting its immediate impact on clinical practice. This landmark paper demonstrates his commitment to rigorous, evidence-based evaluation of emerging technologies, directly informing surgical decision-making for patients with advanced disease. Beyond this, Shen’s broader portfolio explores the optimization of robotic and endoscopic interventions, aiming to reduce morbidity and improve quality of life. His work bridges the gap between cutting-edge endoscopy and robotic surgery, establishing him as a key voice in the evolution of palliative and curative gastrointestinal procedures. For students and researchers, Shen’s career exemplifies how comparative effectiveness research can shape the future of surgical oncology.